questionsmedicales.fr
Enzymes et coenzymes
Enzymes
Hydrolases
Peptide hydrolases
Metalloproteases
Metalloproteases : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Metalloproteases : Questions médicales les plus fréquentes",
"headline": "Metalloproteases : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Metalloproteases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-14",
"dateModified": "2025-03-11",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Metalloproteases"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Peptide hydrolases",
"url": "https://questionsmedicales.fr/mesh/D010447",
"about": {
"@type": "MedicalCondition",
"name": "Peptide hydrolases",
"code": {
"@type": "MedicalCode",
"code": "D010447",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Metalloendopeptidases",
"alternateName": "Metalloendopeptidases",
"url": "https://questionsmedicales.fr/mesh/D008666",
"about": {
"@type": "MedicalCondition",
"name": "Metalloendopeptidases",
"code": {
"@type": "MedicalCode",
"code": "D008666",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.374"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Collagenases",
"alternateName": "Collagenases",
"url": "https://questionsmedicales.fr/mesh/D017364",
"about": {
"@type": "MedicalCondition",
"name": "Collagenases",
"code": {
"@type": "MedicalCode",
"code": "D017364",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.374.205"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Microbial collagenase",
"alternateName": "Microbial Collagenase",
"url": "https://questionsmedicales.fr/mesh/D003012",
"about": {
"@type": "MedicalCondition",
"name": "Microbial collagenase",
"code": {
"@type": "MedicalCode",
"code": "D003012",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.374.205.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Microbial collagenase",
"alternateName": "Microbial Collagenase",
"url": "https://questionsmedicales.fr/mesh/D003012",
"about": {
"@type": "MedicalCondition",
"name": "Microbial collagenase",
"code": {
"@type": "MedicalCode",
"code": "D003012",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.374.205.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Enzymes de conversion de l'endothéline",
"alternateName": "Endothelin-Converting Enzymes",
"url": "https://questionsmedicales.fr/mesh/D000072396",
"about": {
"@type": "MedicalCondition",
"name": "Enzymes de conversion de l'endothéline",
"code": {
"@type": "MedicalCode",
"code": "D000072396",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.374.229"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gelatinases",
"alternateName": "Gelatinases",
"url": "https://questionsmedicales.fr/mesh/D018093",
"about": {
"@type": "MedicalCondition",
"name": "Gelatinases",
"code": {
"@type": "MedicalCode",
"code": "D018093",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.374.252"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Insulinase",
"alternateName": "Insulysin",
"url": "https://questionsmedicales.fr/mesh/D007339",
"about": {
"@type": "MedicalCondition",
"name": "Insulinase",
"code": {
"@type": "MedicalCode",
"code": "D007339",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.374.300"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Lysostaphin",
"alternateName": "Lysostaphin",
"url": "https://questionsmedicales.fr/mesh/D008248",
"about": {
"@type": "MedicalCondition",
"name": "Lysostaphin",
"code": {
"@type": "MedicalCode",
"code": "D008248",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.374.452"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Matrix metalloproteinases",
"alternateName": "Matrix Metalloproteinases",
"url": "https://questionsmedicales.fr/mesh/D020782",
"about": {
"@type": "MedicalCondition",
"name": "Matrix metalloproteinases",
"code": {
"@type": "MedicalCode",
"code": "D020782",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.374.525"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Matrix metalloproteinase 14",
"alternateName": "Matrix Metalloproteinase 14",
"url": "https://questionsmedicales.fr/mesh/D053511",
"about": {
"@type": "MedicalCondition",
"name": "Matrix metalloproteinase 14",
"code": {
"@type": "MedicalCode",
"code": "D053511",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.374.525.300.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Matrix metalloproteinase 15",
"alternateName": "Matrix Metalloproteinase 15",
"url": "https://questionsmedicales.fr/mesh/D053517",
"about": {
"@type": "MedicalCondition",
"name": "Matrix metalloproteinase 15",
"code": {
"@type": "MedicalCode",
"code": "D053517",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.374.525.300.625"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Matrix metalloproteinase 16",
"alternateName": "Matrix Metalloproteinase 16",
"url": "https://questionsmedicales.fr/mesh/D053513",
"about": {
"@type": "MedicalCondition",
"name": "Matrix metalloproteinase 16",
"code": {
"@type": "MedicalCode",
"code": "D053513",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.374.525.300.750"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Matrix metalloproteinase 14",
"alternateName": "Matrix Metalloproteinase 14",
"url": "https://questionsmedicales.fr/mesh/D053511",
"about": {
"@type": "MedicalCondition",
"name": "Matrix metalloproteinase 14",
"code": {
"@type": "MedicalCode",
"code": "D053511",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.374.525.300.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Matrix metalloproteinase 15",
"alternateName": "Matrix Metalloproteinase 15",
"url": "https://questionsmedicales.fr/mesh/D053517",
"about": {
"@type": "MedicalCondition",
"name": "Matrix metalloproteinase 15",
"code": {
"@type": "MedicalCode",
"code": "D053517",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.374.525.300.625"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Matrix metalloproteinase 16",
"alternateName": "Matrix Metalloproteinase 16",
"url": "https://questionsmedicales.fr/mesh/D053513",
"about": {
"@type": "MedicalCondition",
"name": "Matrix metalloproteinase 16",
"code": {
"@type": "MedicalCode",
"code": "D053513",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.374.525.300.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Procollagen peptidase",
"alternateName": "Procollagen N-Endopeptidase",
"url": "https://questionsmedicales.fr/mesh/D011348",
"about": {
"@type": "MedicalCondition",
"name": "Procollagen peptidase",
"code": {
"@type": "MedicalCode",
"code": "D011348",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.374.664"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Bacillus thermoproteolyticus neutral proteinase",
"alternateName": "Thermolysin",
"url": "https://questionsmedicales.fr/mesh/D013820",
"about": {
"@type": "MedicalCondition",
"name": "Bacillus thermoproteolyticus neutral proteinase",
"code": {
"@type": "MedicalCode",
"code": "D013820",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.374.827"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Metalloexopeptidases",
"alternateName": "Metalloexopeptidases",
"url": "https://questionsmedicales.fr/mesh/D045727",
"about": {
"@type": "MedicalCondition",
"name": "Metalloexopeptidases",
"code": {
"@type": "MedicalCode",
"code": "D045727",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.555"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Carboxypeptidases A",
"alternateName": "Carboxypeptidases A",
"url": "https://questionsmedicales.fr/mesh/D043422",
"about": {
"@type": "MedicalCondition",
"name": "Carboxypeptidases A",
"code": {
"@type": "MedicalCode",
"code": "D043422",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.555.350"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Cystinyl aminopeptidase",
"alternateName": "Cystinyl Aminopeptidase",
"url": "https://questionsmedicales.fr/mesh/D010122",
"about": {
"@type": "MedicalCondition",
"name": "Cystinyl aminopeptidase",
"code": {
"@type": "MedicalCode",
"code": "D010122",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.555.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Glutamate carboxypeptidase II",
"alternateName": "Glutamate Carboxypeptidase II",
"url": "https://questionsmedicales.fr/mesh/D043425",
"about": {
"@type": "MedicalCondition",
"name": "Glutamate carboxypeptidase II",
"code": {
"@type": "MedicalCode",
"code": "D043425",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.555.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Glutamyl aminopeptidase",
"alternateName": "Glutamyl Aminopeptidase",
"url": "https://questionsmedicales.fr/mesh/D043384",
"about": {
"@type": "MedicalCondition",
"name": "Glutamyl aminopeptidase",
"code": {
"@type": "MedicalCode",
"code": "D043384",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.555.600"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Leucyl Aminopeptidase",
"alternateName": "Leucyl Aminopeptidase",
"url": "https://questionsmedicales.fr/mesh/D007931",
"about": {
"@type": "MedicalCondition",
"name": "Leucyl Aminopeptidase",
"code": {
"@type": "MedicalCode",
"code": "D007931",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.555.700"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Lysine carboxypeptidase",
"alternateName": "Lysine Carboxypeptidase",
"url": "https://questionsmedicales.fr/mesh/D001121",
"about": {
"@type": "MedicalCondition",
"name": "Lysine carboxypeptidase",
"code": {
"@type": "MedicalCode",
"code": "D001121",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.555.750"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Metalloproteases",
"alternateName": "Metalloproteases",
"code": {
"@type": "MedicalCode",
"code": "D045726",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Tania Fontanil",
"url": "https://questionsmedicales.fr/author/Tania%20Fontanil",
"affiliation": {
"@type": "Organization",
"name": "Departamento de Bioquímica y Biología Molecular, Universidad de Oviedo, 33006 Oviedo, Spain."
}
},
{
"@type": "Person",
"name": "Yamina Mohamedi",
"url": "https://questionsmedicales.fr/author/Yamina%20Mohamedi",
"affiliation": {
"@type": "Organization",
"name": "Departamento de Bioquímica y Biología Molecular, Universidad de Oviedo, 33006 Oviedo, Spain."
}
},
{
"@type": "Person",
"name": "Teresa Cobo",
"url": "https://questionsmedicales.fr/author/Teresa%20Cobo",
"affiliation": {
"@type": "Organization",
"name": "Departamento de Cirugía y Especialidades Médico-Quirúrgicas, Universidad de Oviedo, 33006 Oviedo, Spain."
}
},
{
"@type": "Person",
"name": "Santiago Cal",
"url": "https://questionsmedicales.fr/author/Santiago%20Cal",
"affiliation": {
"@type": "Organization",
"name": "Departamento de Bioquímica y Biología Molecular, Universidad de Oviedo, 33006 Oviedo, Spain."
}
},
{
"@type": "Person",
"name": "Álvaro J Obaya",
"url": "https://questionsmedicales.fr/author/%C3%81lvaro%20J%20Obaya",
"affiliation": {
"@type": "Organization",
"name": "Departamento de Biología Funcional, Área de Fisiología, Universidad de Oviedo, 33006 Oviedo, Spain."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Prostate and metastasis-directed focal therapy in prostate cancer: hype or hope?",
"datePublished": "2023-02-03",
"url": "https://questionsmedicales.fr/article/36718727",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/14737140.2023.2171991"
}
},
{
"@type": "ScholarlyArticle",
"name": "The combined role of MRI prostate and prostate health index in improving detection of significant prostate cancer in a screening population of Chinese men.",
"datePublished": "2023-05-02",
"url": "https://questionsmedicales.fr/article/37534902",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.4103/aja20239"
}
},
{
"@type": "ScholarlyArticle",
"name": "Simultaneous thulium laser resection of the prostate and transperineal prostate biopsy in clinically diagnosed metastatic prostate cancer with bladder outlet obstruction.",
"datePublished": "2023-08-18",
"url": "https://questionsmedicales.fr/article/37596454",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10103-023-03848-5"
}
},
{
"@type": "ScholarlyArticle",
"name": "Staging Prostate Cancer with",
"datePublished": "2023-04-28",
"url": "https://questionsmedicales.fr/article/37116912",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2967/jnumed.122.265371"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prostate MRI Qualification:",
"datePublished": "2022-05-11",
"url": "https://questionsmedicales.fr/article/35544372",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2214/AJR.22.27615"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Enzymes et coenzymes",
"item": "https://questionsmedicales.fr/mesh/D045762"
},
{
"@type": "ListItem",
"position": 3,
"name": "Enzymes",
"item": "https://questionsmedicales.fr/mesh/D004798"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hydrolases",
"item": "https://questionsmedicales.fr/mesh/D006867"
},
{
"@type": "ListItem",
"position": 5,
"name": "Peptide hydrolases",
"item": "https://questionsmedicales.fr/mesh/D010447"
},
{
"@type": "ListItem",
"position": 6,
"name": "Metalloproteases",
"item": "https://questionsmedicales.fr/mesh/D045726"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Metalloproteases - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Metalloproteases",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Metalloproteases",
"description": "Comment diagnostiquer une dysfonction des métalloprotéases ?\nQuels marqueurs sont utilisés pour le diagnostic ?\nLes imageries sont-elles utiles pour le diagnostic ?\nQuels tests génétiques sont disponibles ?\nComment évaluer l'activité enzymatique ?",
"url": "https://questionsmedicales.fr/mesh/D045726?mesh_terms=Prostatic+Neoplasms&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Metalloproteases",
"description": "Quels symptômes indiquent une surproduction de métalloprotéases ?\nLes symptômes varient-ils selon le type de métalloprotéases ?\nQuels signes cliniques sont associés à une déficience ?\nLes symptômes sont-ils toujours visibles ?\nComment les symptômes évoluent-ils avec l'âge ?",
"url": "https://questionsmedicales.fr/mesh/D045726?mesh_terms=Prostatic+Neoplasms&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Metalloproteases",
"description": "Comment prévenir les maladies liées aux métalloprotéases ?\nLes suppléments nutritionnels sont-ils utiles ?\nL'évitement de certains aliments est-il recommandé ?\nLe contrôle du stress est-il important ?\nLes examens réguliers sont-ils nécessaires ?",
"url": "https://questionsmedicales.fr/mesh/D045726?mesh_terms=Prostatic+Neoplasms&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Metalloproteases",
"description": "Quels traitements ciblent les métalloprotéases ?\nLes thérapies géniques sont-elles une option ?\nComment les anti-inflammatoires aident-ils ?\nLes traitements sont-ils personnalisés ?\nQuels sont les effets secondaires des inhibiteurs ?",
"url": "https://questionsmedicales.fr/mesh/D045726?mesh_terms=Prostatic+Neoplasms&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Metalloproteases",
"description": "Quelles complications peuvent survenir avec une suractivité ?\nLes complications sont-elles réversibles ?\nComment les complications affectent-elles la qualité de vie ?\nLes complications sont-elles prévisibles ?\nQuelles sont les complications liées à une déficience ?",
"url": "https://questionsmedicales.fr/mesh/D045726?mesh_terms=Prostatic+Neoplasms&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Metalloproteases",
"description": "Quels facteurs augmentent le risque de dysfonction ?\nLes antécédents familiaux jouent-ils un rôle ?\nLe tabagisme est-il un facteur de risque ?\nLe stress chronique influence-t-il le risque ?\nL'exposition à des toxines est-elle un facteur ?",
"url": "https://questionsmedicales.fr/mesh/D045726?mesh_terms=Prostatic+Neoplasms&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysfonction des métalloprotéases ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et des biopsies tissulaires peuvent évaluer l'activité des métalloprotéases."
}
},
{
"@type": "Question",
"name": "Quels marqueurs sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les niveaux de métalloprotéases dans le sérum ou les tissus peuvent servir de marqueurs diagnostiques."
}
},
{
"@type": "Question",
"name": "Les imageries sont-elles utiles pour le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'imagerie peut aider à visualiser les tissus affectés par des déséquilibres enzymatiques."
}
},
{
"@type": "Question",
"name": "Quels tests génétiques sont disponibles ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques peuvent identifier des mutations affectant la production de métalloprotéases."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'activité enzymatique ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests enzymatiques spécifiques mesurent l'activité des métalloprotéases dans les échantillons."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une surproduction de métalloprotéases ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une inflammation, des douleurs articulaires et des lésions tissulaires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de métalloprotéases ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, différents types de métalloprotéases peuvent causer des symptômes variés selon les tissus affectés."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques sont associés à une déficience ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une cicatrisation lente et des anomalies dans la matrice extracellulaire peuvent être observées."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils toujours visibles ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, certaines dysfonctions peuvent être asymptomatiques jusqu'à des stades avancés."
}
},
{
"@type": "Question",
"name": "Comment les symptômes évoluent-ils avec l'âge ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'activité des métalloprotéases peut augmenter avec l'âge, aggravant les symptômes dégénératifs."
}
},
{
"@type": "Question",
"name": "Comment prévenir les maladies liées aux métalloprotéases ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain, incluant une alimentation équilibrée et de l'exercice, peut aider."
}
},
{
"@type": "Question",
"name": "Les suppléments nutritionnels sont-ils utiles ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains suppléments, comme les antioxydants, peuvent soutenir la fonction des métalloprotéases."
}
},
{
"@type": "Question",
"name": "L'évitement de certains aliments est-il recommandé ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, réduire les aliments pro-inflammatoires peut aider à réguler l'activité des métalloprotéases."
}
},
{
"@type": "Question",
"name": "Le contrôle du stress est-il important ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut influencer l'activité des métalloprotéases, donc sa gestion est cruciale."
}
},
{
"@type": "Question",
"name": "Les examens réguliers sont-ils nécessaires ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens réguliers peuvent aider à détecter précocement des déséquilibres enzymatiques."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent les métalloprotéases ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des inhibiteurs spécifiques des métalloprotéases sont utilisés pour traiter certaines maladies."
}
},
{
"@type": "Question",
"name": "Les thérapies géniques sont-elles une option ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la thérapie génique peut corriger des mutations affectant la production de métalloprotéases."
}
},
{
"@type": "Question",
"name": "Comment les anti-inflammatoires aident-ils ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent réduire l'inflammation causée par une suractivité des métalloprotéases."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils personnalisés ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent être adaptés en fonction du type de métalloprotéases impliqué."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des inhibiteurs ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les inhibiteurs peuvent causer des effets secondaires comme des troubles gastro-intestinaux."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une suractivité ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des maladies dégénératives, comme l'arthrite, peuvent résulter d'une suractivité des métalloprotéases."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement approprié, d'autres non."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent entraîner des douleurs chroniques et une mobilité réduite, affectant la qualité de vie."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles prévisibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être prévisibles en surveillant les niveaux d'activité enzymatique."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications liées à une déficience ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une cicatrisation lente et des infections peuvent survenir en raison d'une déficience en métalloprotéases."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de dysfonction ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge, le mode de vie sédentaire et une alimentation déséquilibrée augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de maladies liées aux métalloprotéases peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Le tabagisme est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut exacerber l'activité des métalloprotéases et augmenter les maladies associées."
}
},
{
"@type": "Question",
"name": "Le stress chronique influence-t-il le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut perturber l'équilibre des métalloprotéases, augmentant le risque de maladies."
}
},
{
"@type": "Question",
"name": "L'exposition à des toxines est-elle un facteur ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à certaines toxines environnementales peut affecter l'activité des métalloprotéases."
}
}
]
}
]
}
The paradigm of focal therapy's role in metastatic patients is being challenged by evolving attitudes and emerging data. At the current time, specifically regarding prostate cancer, does the evidence ...
We searched the literature via PubMed, MEDLINE, and Embase for studies from 2014 to the present addressing focal therapy with non-palliative intent in metastatic prostate cancer patients, emphasizing ...
Current evidence is strongest, and in our opinion practice-changing, for prostate-directed RT in de novo metastatic patients with low metastatic burden. Metastasis-directed therapy with SBRT is consis...
Using prostate-specific antigen (PSA) for prostate cancer (PCa) screening led to overinvestigation and overdiagnosis of indolent PCa. We aimed to investigate the value of prostate health index (PHI) a...
Metastatic prostate cancer (mPCa) patients complicated with bladder outlet obstruction (BOO) are often referred to a urologist. Androgen deprivation therapy (ADT) combined with indwelling catheter usu...
Although prostate-specific membrane antigen (PSMA) PET/CT has been shown valuable for staging biopsy-proven [B(+)] high-risk prostate cancer, elderly patients are occasionally referred for PSMA PET/CT...
Prostate MRI is now established as a first-line investigation for individuals presenting with suspected localized or locally advanced prostate cancer. Successful delivery of the MRI-directed pathway f...
Prostate cancer has a long disease history and a wide variety and uncertainty in individual patients' clinical progress. In recent years, we have seen a revolutionary advance in both prostate cancer p...
There is a clinical need to identify patients with an elevated PSA who would benefit from prostate biopsy due to the presence of clinically significant prostate cancer (CSCaP). We have previously repo...
To further develop and adapt the MiCheck® Prostate test so it can be performed using a standard clinical chemistry analyzer and characterize its performance using the MiCheck-01 clinical trial sample ...
About 358 patient samples from the MiCheck-01 US clinical trial were used for the development of the MiCheck® Prostate test. These consisted of 46 controls, 137 non-CaP, 62 non-CSCaP, and 113 CSCaP....
Serum analyte concentrations for cellular growth factors were determined using custom-made Luminex-based R&D Systems multi-analyte kits. Analytes that can also be measured using standard chemistry ana...
Logistic regression modeling with Monte Carlo cross-validation was used to identify Human Epidydimal Protein 4 (HE4) as an analyte able to significantly improve the algorithm specificity at 95% sensit...
The MiCheck® logistic regression model was developed and consisted of PSA, %free PSA, DRE, and HE4. The model differentiated clinically significant cancer from no cancer or not-clinically significant ...
The MiCheck® Prostate test identifies clinically significant prostate cancer with high sensitivity and negative predictive value (NPV). It can be performed in a clinical laboratory using a Roche Cobas...
Prostate health index (PHI) and, more recently, Proclarix have been proposed as serum biomarkers for prostate cancer (PCa). In this study, we aimed to evaluate Proclarix and PHI for predicting clinica...
Proclarix and PHI were measured using samples of 344 men from two different centers. All patients underwent prostate biopsy, and among those, 188 men with PCa on biopsy had an additional radical prost...
The cohort median age and PSA were 65 (interquartile range [IQR]: 60-71) and 5.6 (IQR: 4.3-7.2) ng/ml, respectively. CsPCa was diagnosed in 161 (47%) men based on the RP specimen. ROC analysis showed ...
Results of this study show that both Proclarix and PHI accurately detect the presence of csPCa. The model combining Proclarix and PHI revealed the synergistic effect and improved the diagnostic perfor...
Transperineal (TP) multiparametric magnetic resonance imaging (mpMRI)-targeted biopsy (TBx) has been shown to detect more clinically significant (cs) prostate cancer (PCa) than standard template biops...
We identified all men who with suspicious lesions on mpMRI and underwent TP TBx (3-core) and concomitant SBx (20-core) in our single hospital from September 2019 to February 2021. Clinical, MRI and bi...
Three hundred and one (n = 301) men were included. The median prostate volume by MRI was 45 ml. The patients were divided by prostate volume into three groups: ≤30ml group (19.9%), >30 to ≤45 ml group...
Our data suggest that performing TBx with limited additional cores may potentially achieve the same csPCa detection rate as the combined SBx and TBx in smaller prostates....
We sought to determine whether two soluble forms with different size of mtDNA are linked to prostatic inflammation, and whether they discriminate prostate cancer (PCa) from inflammatory prostatic cond...
Histopathologically diagnosed prostatitis, PCa and benign prostatic hyperplasia patients (n = 93) were enrolled in this study and they were categorized as with and without prostate inflammation. Quant...
The urine mtDNA-79 and mtDNA-230 were significantly increased in patients with prostate inflammation compared with those in without inflammation. Here, 79-bp fragment of apoptotic origin was significa...
Our results demonstrate that shorter cf-mtDNA fragment size in particular, increase in the presence of prostate inflammation in post-prostatic massage urine but both fragments could never improve seru...